Filing Details

Accession Number:
0001181431-13-031065
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-28 18:40:29
Reporting Period:
2013-05-23
Filing Date:
2013-05-28
Accepted Time:
2013-05-28 18:40:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201888 C Robert Merton 10390 Pacific Center Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Acquisiton 2013-05-23 5,953 $0.01 75,781 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.01 Par Value Nonstatutory Stock Option (right to buy) Acquisiton 2013-05-23 39,619 $0.00 39,619 $3.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
298,741 2014-05-23 2023-05-22 No 4 A Direct
Footnotes
  1. Shares were acquired pursuant to a restricted stock grant.
  2. The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2014.
  3. This balance includes 5,953 of unvested restricted stock units.